PMID: 7581124Jul 1, 1995Paper

Severe hepatotoxicity from granulocyte-macrophage colony-stimulating factor administered after autologous bone marrow transplantation

Bone Marrow Transplantation
H M PrinceA Keating

Abstract

We report a case of life-threatening hepatotoxicity following GM-CSF therapy after autologous bone marrow transplantation. GM-CSF hepatotoxicity should now be considered in the differential diagnosis of post-transplant liver disease.

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
F Kimura
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
A Pedrazzini
© 2021 Meta ULC. All rights reserved